New hope for men with advanced penile cancer when chemotherapy fails
NCT ID NCT03391479
Summary
This study is testing whether the immunotherapy drug avelumab can help men with advanced penile cancer that has spread or cannot be removed by surgery. It is for patients who are not suitable for standard platinum-based chemotherapy or whose cancer has continued to grow despite that treatment. The main goal is to see if the treatment can shrink or stop the growth of tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.